Current views on tumor mutational burden in patients with non-small cell lung cancer treated by immune checkpoint inhibitors

In the last few years, the treatment of patients with non-small cell lung cancer (NSCLC) has impressively benefitted from immunotherapy, in particular from the inhibition of immune checkpoints such as programmed cell death-1 (PD-1) and programmed cell death ligand-1 (PD-L1). However, despite the sig...

Cur síos iomlán

Na minha lista:
Sonraí Bibleagrafaíochta
Foilsithe in:J Thorac Dis
Main Authors: Berland, Léa, Heeke, Simon, Humbert, Olivier, Macocco, Adam, Long-Mira, Elodie, Lassalle, Sandra, Lespinet-Fabre, Virginie, Lalvée, Salomé, Bordone, Olivier, Cohen, Charlotte, Leroy, Sylvie, Hofman, Véronique, Hofman, Paul, Ilié, Marius
Formáid: Artigo
Teanga:Inglês
Foilsithe: AME Publishing Company 2019
Ábhair:
Review Article
Rochtain Ar Líne:https://ncbi.nlm.nih.gov/pmc/articles/PMC6353746/
https://ncbi.nlm.nih.gov/pubmed/30775030
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.21037/jtd.2018.11.102
Clibeanna: Cuir Clib Leis
Gan Chlibeanna, Bí ar an gcéad duine leis an taifead seo a chlibeáil!

Míreanna Comhchosúla